Greg Simon named executive director of national cancer moonshot initiative

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

GREG SIMON was named executive director of the national moonshot cancer initiative by Vice President Joe Biden. Previously, he helped start the charity FasterCures in 2003. In 2009, he became senior vice president for patient engagement at Pfizer. Most recently, he was chief executive of Poliwogg, a financial services company. Simon was diagnosed with leukemia...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have ā€œflooded the zoneā€ā€”the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services.Ā 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies.Ā 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login